Scaling the Corner Drugstore: The Operational Engine Behind Neighbourly Pharmacy's National Expansion

TORONTO, ON – November 05, 2026 — In the retail healthcare sector, the leap from a promising prototype to a profitable, national powerhouse rarely happens through organic growth alone. It requires aggressive scaling, meticulous backend integration, and an operational framework capable of standardizing hundreds of disparate local businesses. This week, the industry received a clear signal of exactly who is driving this complex machinery at Canada’s largest network of independent community pharmacies.

At a November 3 ceremony in Chicago, Drug Store News (DSN) honored two senior executives from Neighbourly Pharmacy Inc. as 2026 Top Women in Health, Wellness & Beauty. Alicia Matthews-Kent, Chief Operating Officer, and Veneta Anand O'Garro, Senior Director of Rx Pricing and Payor Relations, were recognized in the Business Excellence and Commitment to Care categories, respectively.

While industry awards are often viewed as mere corporate accolades, for investors and market analysts, they frequently serve as lagging indicators of internal operational maturity. Having two executives recognized in the same year alongside leaders from retail giants like Amazon Pharmacy, CVS Health, and Walmart highlights Neighbourly’s transition from a regional consolidator to a dominant North American healthcare player.

The Operational Engine Behind a 342-Store Footprint

Since its founding in 2015, Neighbourly Pharmacy has executed a relentless "acquisition and integration succession model," targeting independent pharmacy owners looking for an exit strategy. Today, the network boasts 342 locations across Canada. However, acquiring a business is only the first step in commercialization; the true test of profitability lies in integration.

This is where Matthews-Kent’s recognition in the Business Excellence category becomes highly relevant to the company's bottom line. Taking the operational helm as COO after joining the company in June 2023, Matthews-Kent brought over two decades of heavy-hitting retail healthcare experience, including foundational tenures at Sobeys and a pivotal role leading healthcare operations for Walmart Canada and developing healthcare strategy at Walmart Mexico.

Scaling a network of independent pharmacies is notoriously difficult. Unlike a standardized franchise model built from the ground up, Neighbourly buys existing local hubs—each with its own legacy software, vendor relationships, and patient cultures. Matthews-Kent’s mandate has been to harmonize these 342 disparate nodes into a unified, high-margin network without destroying the local goodwill that makes community pharmacies valuable in the first place.

Her operational rigor is the linchpin holding together Neighbourly’s aggressive financial maneuvers. Earlier in 2024, the company was taken private by Persistence Capital Partners (PCP) in a massive C$1.2 billion deal, backed by up to C$320 million in structured equity from Brookfield Asset Management. Investors at this scale demand rapid margin optimization and seamless integration of acquisitions, such as the ten additional pharmacies integrated just last month.

"Alicia has helped guide Neighbourly through a period of significant growth while building strong teams and raising the bar on operational excellence," noted Skip Bourdo, Chief Executive Officer of Neighbourly Pharmacy, following the DSN announcement.

Breaking the Glass Counter in Retail Health

The DSN awards, featured in the publication's November 2026 issue, also highlight a broader demographic and strategic shift within healthcare retail. Matthews-Kent and O'Garro are navigating a sector undergoing profound transformation. In Canada, the scope of practice for pharmacists has expanded dramatically. Pharmacists are no longer just dispensing medication; they are assessing and prescribing for minor ailments, conducting comprehensive medication reviews, and serving as primary care access points for millions of Canadians struggling to find family doctors.

This clinical evolution requires a fundamentally different leadership approach. It demands executives who can balance the raw mathematics of retail with the nuanced demands of frontline patient care. Matthews-Kent’s approach has already garnered domestic praise; in June 2026, she was named the first-ever recipient of the Sector Catalyst Award by the Neighbourhood Pharmacy Association of Canada (NPAC) for advancing patient care and access, particularly in rural and underserved communities.

Balancing Profitability with Global Health Equity

If Matthews-Kent represents the operational muscle of Neighbourly’s commercialization, Veneta Anand O'Garro represents the strategic navigation of its revenue streams and community trust. Recognized by DSN in the Commitment to Care category, O'Garro’s corporate title—Senior Director, Rx Pricing and Payor Relations—places her at the very nerve center of the company’s financial viability.

Managing payor relations and navigating the labyrinthine economics of pharmaceutical pricing is a highly commercial, profit-driven mandate. Yet, O'Garro was awarded for her humanitarian leadership of STIMMA, a global non-profit organization dedicated to improving healthcare access through sustainable community partnerships worldwide.

For a modern healthcare corporation, this duality is not a contradiction; it is a commercial necessity. Independent pharmacies survive on patient trust. As Neighbourly scales, it faces the inherent risk of being perceived as a faceless corporate roll-up. O'Garro’s ability to bridge high-level pharmaceutical economics with grassroots health equity initiatives reflects a sophisticated understanding of the modern healthcare market. Expertise in drug pricing can, and should, translate into better access to care, both domestically and internationally.

"Veneta has paired exceptional leadership inside our organization with a dedication to improving access to care in communities around the world," Bourdo stated, emphasizing that this dual focus reflects the core mission of the company.

Navigating the Consolidation Wave

The recognition of these two leaders arrives at a critical juncture for the Canadian pharmacy sector. The industry is a massive economic engine, generating an estimated $22.9 billion in GDP and supporting over 273,000 jobs. Yet, the landscape is highly fragmented. Nearly two-thirds of Canada's 12,558 pharmacy locations remain independently owned or banner-affiliated.

A demographic time bomb is ticking within this independent sector. As a generation of local pharmacy owners nears retirement, the market is experiencing a massive wave of succession-driven consolidation. Neighbourly has positioned itself as the most active buyer in this space, competing against large operators like Shoppers Drug Mart and banner groups like Pharmasave.

To maintain its position as the "partner of choice" for exiting owners, Neighbourly must prove that it can offer more than just a lucrative buyout. It must demonstrate that it has the operational infrastructure to support expanded clinical services and the cultural integrity to maintain community trust. The dual DSN awards for Matthews-Kent and O'Garro signal to the market—and to prospective sellers—that Neighbourly is actively building the sophisticated leadership bench required to turn local pharmacy prototypes into a highly profitable, national healthcare network.